Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the 2018 issue of Paths of Progress.
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Paths of Progress in the mail, please complete this form.
A closer look at creating the "living drugs" at the heart of today's CAR T-cell therapies.
Finding new tools to help the body identify and target cancer tumors hiding in plain sight.
Epigenetics research examines how genes are controlled. Recent evidence may point to it as a new approach to cancer treatment.
Posted on April 27, 2018
Media Contacts
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.